[HTML][HTML] Denosumab: AHFS 92: 24

A Wilcock, S Charlesworth, CS Toller, R Girish… - Journal of Pain and …, 2018 - Elsevier
Therapeutic Reviews aim to provide essential independent information for health professionals
about drugs used in palliative and hospice care. Additional content is available on www.…

[HTML][HTML] Bisphosphonates: AHFS 92: 24

CS Toller, S Charlesworth, M Mihalyo, P Howard… - Journal of Pain and …, 2019 - Elsevier
Therapeutic Reviews aim to provide essential independent information for health professionals
about drugs used in palliative and hospice care. Additional content is available via www.…

41 Mountbatten hampshire place of care review

A White, C Stark-Toller, S Graves - 2024 - spcare.bmj.com
Abstracts Page 1 months with good symptom control including improvements in pain and
delirium. One patient was agitated and died despite treatment before the effects of the …

Compliance with and understanding of advance directives among trainee doctors in the United Kingdom

CAS Toller, MM Budge - Journal of palliative care, 2006 - journals.sagepub.com
Aim To investigate doctors’ response to and understanding of the legal status of advance
directives. Methods A vignette-based study administered at palliative medicine, oncology, …

P-187 Improving access to interventional pain management for palliative care patients

C Besley, C Stark-Toller, J Harding, B Smith - 2023 - spcare.bmj.com
Background Pain is one of the most frequently encountered symptoms in palliative care
patients, and poorly controlled pain is debilitating. Two-thirds of terminally ill cancer patients …

Sodium zirconium cyclosilicate for hyperkalaemia

A Shaikh, CS Toller - BMJ Supportive & Palliative Care, 2023 - spcare.bmj.com
Hyperkalaemia is a life-threatening medical emergency. Treatment usually requires admission
to hospital. This is often inappropriate or unacceptable for patients in a hospice setting. …

P-166 Anaemia; are we reversing the reversible?

A Maslen, C Stark-Toller - 2022 - spcare.bmj.com
Background Anaemia is common amongst patients receiving specialist palliative care. A
2003 study of palliative care patients found that 77% of men and 68.2% of women were …

P-182 Improving education on low residue diets in palliative care

A Broadbent, L Clode, C Stark-Toller - 2022 - spcare.bmj.com
Abstracts Page 1 tolerated and has potential use as a non-invasive tool to evaluate hydration
status in the dying. P-180 CAREGIVER VIEWS AND EXPECTATIONS ABOUT THE USE …

115 Time for a change? Transforming the investigation and management of anaemia in the palliative care population

S Jones, CS Toller - 2021 - spcare.bmj.com
Background Severe anaemia is common in the hospice setting. Causes include anaemia of
chronic disease (ACD) and associated functional iron deficiency (FID), with or without …

130 Measuring serum-ascites albumin gradient to optimize management of ascites in a hospice setting

K Bevan, C Stark-Toller - BMJ Supportive & Palliative Care, 2021 - search.proquest.com
Background Paracentesis for management of ascites is frequently performed in hospices.
Serum-ascites albumin gradient (SAAG) should be measured to guide management. Patients …